Outsmarting Cancer’s Next Move
Next-generation pharmaceuticals engineered to overcome cancer plasticity and stop relapse at the source.
Why We Pioneer
Standard treatments ignore the adaptable cancer stem cells that cause disease recurrence, so we target the root biology of stemness to eradicate relapse at its source.
Our vision is to revolutionize oncology by delivering first-in-class precision therapeutics and diagnostics engineered to overcome cancer relapse and enable definitive, curative outcomes. Learn More
